Concord Biotech (BOM:543960) Inventories, Finished Goods: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543960 Concord Biotech Ltd BOM:543960
90 GF Score
Price ₹1,506.65
GF Value ₹1,701.03
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Concord Biotech Inventories, Finished Goods?

Concord Biotech BOM:543960 +3.72% 90 Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543960 with a GF Score™ of 90/100 and a GF Value™ of ₹1,701.03 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Concord Biotech's quarterly finished goods increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹319 Mil) but then declined from Mar. 2026 (₹319 Mil) to Jun. 2026 (₹0 Mil).

Concord Biotech's annual finished goods increased from Mar. 2024 (₹166 Mil) to Mar. 2025 (₹210 Mil) and increased from Mar. 2025 (₹210 Mil) to Mar. 2026 (₹319 Mil).

Concord Biotech Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Concord Biotech's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Biotech Inventories, Finished Goods Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial 221.88 148.02 165.98 210.35 319.16

Concord Biotech Quarterly Data
Mar20 Mar21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 319.16 0.00
BOM:543960
90GF Score
Concord Biotech Ltd BOM:543960
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Biotech Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹0 Mil mean?
Concord Biotech (BOM:543960) has a Inventories, Finished Goods of ₹0 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Concord Biotech and its competitors.
Is Concord Biotech's Inventories, Finished Goods too high?
Concord Biotech's current Inventories, Finished Goods is ₹0 Mil. Overall, Concord Biotech has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Concord Biotech's Inventories, Finished Goods compare to VRTX and REGN?
Concord Biotech's Inventories, Finished Goods of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Concord Biotech and its competitors. Concord Biotech's current Inventories, Finished Goods is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Biotech stock overvalued right now?
Based on GuruFocus' analysis, Concord Biotech (BOM:543960) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,701.03, compared to a current price of ₹1,506.65 — trading 11.4% below its estimated fair value. The current Inventories, Finished Goods is ₹0 Mil. Concord Biotech's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Concord Biotech (BOM:543960), the current Inventories, Finished Goods is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Biotech (BOM:543960) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Biotech stock appears to be undervalued. The current stock price of ₹1,506.65 is trading 11.4% below its estimated GF Value™ of ₹1,701.03. GuruFocus considers Concord Biotech to be Modestly Undervalued.

Key valuation signals for BOM:543960:

  • Inventories, Finished Goods: ₹0 Mil
  • GF Value™: ₹1,701.03 vs. price of ₹1,506.65 (11.4% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the BOM:543960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Concord Biotech Business Description

Other Exchanges CONCORDBIO:India
Address Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products. Geographically Company operates in two segments within India and outside India, having majority revenue from India.
90GF Score

Get the complete analysis for BOM:543960

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,506.65
Price
₹1,701.03
GF Value